MedPAC > Our Work > Drugs, Devices, and Tests > MedPAC comment on CMS’s proposed rule on CY 2021 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies
MedPAC comment on CMS’s proposed rule on CY 2021 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies